148 related articles for article (PubMed ID: 23485734)
1. R132C IDH1 mutations are found in spindle cell hemangiomas and not in other vascular tumors or malformations.
Kurek KC; Pansuriya TC; van Ruler MA; van den Akker B; Luks VL; Verbeke SL; Kozakewich HP; Sciot R; Lev D; Lazar AJ; Fletcher CD; Bovée JV
Am J Pathol; 2013 May; 182(5):1494-500. PubMed ID: 23485734
[TBL] [Abstract][Full Text] [Related]
2. Mutational analysis using Sanger and next generation sequencing in sporadic spindle cell hemangiomas: A study of 19 cases.
Ten Broek RW; Bekers EM; de Leng WWJ; Strengman E; Tops BBJ; Kutzner H; Leeuwis JW; van Gorp JM; Creytens DH; Mentzel T; van Diest PJ; Eijkelenboom A; Flucke U
Genes Chromosomes Cancer; 2017 Dec; 56(12):855-860. PubMed ID: 28845532
[TBL] [Abstract][Full Text] [Related]
3. Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome.
Pansuriya TC; van Eijk R; d'Adamo P; van Ruler MA; Kuijjer ML; Oosting J; Cleton-Jansen AM; van Oosterwijk JG; Verbeke SL; Meijer D; van Wezel T; Nord KH; Sangiorgi L; Toker B; Liegl-Atzwanger B; San-Julian M; Sciot R; Limaye N; Kindblom LG; Daugaard S; Godfraind C; Boon LM; Vikkula M; Kurek KC; Szuhai K; French PJ; Bovée JV
Nat Genet; 2011 Nov; 43(12):1256-61. PubMed ID: 22057234
[TBL] [Abstract][Full Text] [Related]
4. [Spindle cell hemangioma: a clinicopathological and molecular analysis of eight cases].
Hu X; Zou Y; Chen HJ; He X; Zhang HY
Zhonghua Bing Li Xue Za Zhi; 2022 Mar; 51(3):196-201. PubMed ID: 35249281
[No Abstract] [Full Text] [Related]
5. IDH1 R132C and ERC2 L309I Mutations Contribute to the Development of Maffucci's Syndrome.
Cheng P; Chen K; Zhang S; Mu KT; Liang S; Zhang Y
Front Endocrinol (Lausanne); 2021; 12():763349. PubMed ID: 34790172
[TBL] [Abstract][Full Text] [Related]
6. IDH1 immunohistochemistry reactivity and mosaic IDH1 or IDH2 somatic mutations in pediatric sporadic enchondroma and enchondromatosis.
Saiji E; Pause FG; Lascombes P; Cerato Biderbost C; Marq NL; Berczy M; Merlini L; Rougemont AL
Virchows Arch; 2019 Nov; 475(5):625-636. PubMed ID: 31240473
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical Detection and Molecular Characterization of IDH-mutant Sinonasal Undifferentiated Carcinomas.
Mito JK; Bishop JA; Sadow PM; Stelow EB; Faquin WC; Mills SE; Krane JF; French CA; Fletcher CDM; Hornick JL; Sholl LM; Jo VY
Am J Surg Pathol; 2018 Aug; 42(8):1067-1075. PubMed ID: 29683816
[TBL] [Abstract][Full Text] [Related]
8. Somatic
Brown NJ; Ye Z; Stutterd C; Jayasinghe SI; Schneider A; Mullen S; Mandelstam SA; Hildebrand MS
Cold Spring Harb Mol Case Stud; 2021 Dec; 7(6):. PubMed ID: 34588213
[TBL] [Abstract][Full Text] [Related]
9. A new sensitive PCR assay for one-step detection of 12 IDH1/2 mutations in glioma.
Catteau A; Girardi H; Monville F; Poggionovo C; Carpentier S; Frayssinet V; Voss J; Jenkins R; Boisselier B; Mokhtari K; Sanson M; Peyro-Saint-Paul H; Giannini C
Acta Neuropathol Commun; 2014 Jun; 2():58. PubMed ID: 24889502
[TBL] [Abstract][Full Text] [Related]
10. A case of Maffucci syndrome with a buccal hemangioma harboring a mutation in IDH1.
Ichimura N; Yamamoto N; Toyama N; Hibi H
Oral Oncol; 2021 Nov; 122():105553. PubMed ID: 34624834
[TBL] [Abstract][Full Text] [Related]
11. Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2.
Amary MF; Damato S; Halai D; Eskandarpour M; Berisha F; Bonar F; McCarthy S; Fantin VR; Straley KS; Lobo S; Aston W; Green CL; Gale RE; Tirabosco R; Futreal A; Campbell P; Presneau N; Flanagan AM
Nat Genet; 2011 Nov; 43(12):1262-5. PubMed ID: 22057236
[TBL] [Abstract][Full Text] [Related]
12. Cell-free DNA from plasma as a promising alternative for detection of gene mutations in patients with Maffucci syndrome.
Sun Y; Fan X; Rao Y; Wang Z; Wang D; Yang X; Zheng L; Wen M; Cai R; Su L
Hereditas; 2022 Jan; 159(1):4. PubMed ID: 35042566
[TBL] [Abstract][Full Text] [Related]
13. Molecular alterations of isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) metabolic genes and additional genetic mutations in newly diagnosed acute myeloid leukemia patients.
Chotirat S; Thongnoppakhun W; Promsuwicha O; Boonthimat C; Auewarakul CU
J Hematol Oncol; 2012 Mar; 5():5. PubMed ID: 22397365
[TBL] [Abstract][Full Text] [Related]
14. Maffucci syndrome and neoplasms: a case report and review of the literature.
Prokopchuk O; Andres S; Becker K; Holzapfel K; Hartmann D; Friess H
BMC Res Notes; 2016 Feb; 9():126. PubMed ID: 26920730
[TBL] [Abstract][Full Text] [Related]
15. Somatic IDH1 mutation in a pituitary adenoma of a patient with Maffucci syndrome.
Hao S; Hong CS; Feng J; Yang C; Chittiboina P; Zhang J; Zhuang Z
J Neurosurg; 2016 Jun; 124(6):1562-7. PubMed ID: 26473790
[TBL] [Abstract][Full Text] [Related]
16. IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours.
Amary MF; Bacsi K; Maggiani F; Damato S; Halai D; Berisha F; Pollock R; O'Donnell P; Grigoriadis A; Diss T; Eskandarpour M; Presneau N; Hogendoorn PC; Futreal A; Tirabosco R; Flanagan AM
J Pathol; 2011 Jul; 224(3):334-43. PubMed ID: 21598255
[TBL] [Abstract][Full Text] [Related]
17. Establishment of a multi-specific monoclonal antibody MsMab-1 recognizing both IDH1 and IDH2 mutations.
Kato Kaneko M; Ogasawara S; Kato Y
Tohoku J Exp Med; 2013 Jun; 230(2):103-9. PubMed ID: 23782684
[TBL] [Abstract][Full Text] [Related]
18. Molecular epidemiology of IDH2 hotspot mutations in cancer and immunohistochemical detection of R172K, R172G, and R172M variants.
Dogan S; Frosina D; Geronimo JA; Hernandez E; Mohanty A; Bale T; Hechtman JF; Arcila ME; Hameed MR; Jungbluth AA
Hum Pathol; 2020 Dec; 106():45-53. PubMed ID: 33017591
[TBL] [Abstract][Full Text] [Related]
19. Maffucci syndrome complicated by three different central nervous system tumors sharing an IDH1 R132C mutation: case report.
Nejo T; Tanaka S; Ikemura M; Nomura M; Takayanagi S; Shin M; Ushiku T; Shibahara J; Saito N; Mukasa A
J Neurosurg; 2018 Dec; 131(6):1829-1834. PubMed ID: 30579273
[TBL] [Abstract][Full Text] [Related]
20. Frequent IDH1/2 mutations in intracranial chondrosarcoma: a possible diagnostic clue for its differentiation from chordoma.
Arai M; Nobusawa S; Ikota H; Takemura S; Nakazato Y
Brain Tumor Pathol; 2012 Oct; 29(4):201-6. PubMed ID: 22323113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
